Clinical trial
A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
NCT05396235 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
- Lead sponsor
- Tanabe Pharma Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 3, 2022
- Completion date
- December 24, 2022
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy adult males